Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1

Abstract Despite their potent antitumor activity, clinical application of immune checkpoint inhibitors has been significantly limited by their poor response rates (<30%) in cancer patients, primarily due to immunosuppressive tumor microenvironments. As a representative immune escape mechanism, cance...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jung Min Shin, Chan‐Hyeong Lee, Soyoung Son, Chan Ho Kim, Jae Ah Lee, Hyewon Ko, Sol Shin, Seok Ho Song, Seong‐Sik Park, Ju‐Hyun Bae, Ju‐Mi Park, Eun‐Ji Choe, Moon‐Chang Baek, Jae Hyung Park
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2022-02-01
Ráidu:	Advanced Science
Fáttát:	combination therapy exosomal PD‐L1 exosome immune checkpoint therapy immune escape tumor microenvironment
Liŋkkat:	https://doi.org/10.1002/advs.202103245
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!